Clinical Trials Browser

Venous Thrombosis

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT06149533 2023-11-29

Thrombosis

Phase 3 Not yet recruiting

366 enrolled

Neoplasms, Venous Thrombosis

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT04462003 2020-07-08

DVT

Phase 3 Unknown

100 enrolled

Neoplasms, Venous Thrombosis

NCT04309240 2020-03-16

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

Phase 3 Unknown

204 enrolled

Neoplasms, Venous Thrombosis

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Phase 3 Unknown

99 enrolled

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

Phase 3 Terminated

7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

NCT01164046 2014-12-03

Longheva

Phase 3 Terminated

56 enrolled

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Phase 3 Completed

512 enrolled

CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Clinical Trials

TALENTOP

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Thrombosis

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

DVT

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

Longheva

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients